All News

In the midst of unprecedented disaster, pharmacists and pharmacies were prepared.

Why the agency says the approval of Novartis’ new therapy is historic.

New therapies hold great promise-and great danger.

The recall is just the latest in a bacterial contamination scare.

Robberies are never a good thing, but sometimes they make for the craziest stories.

An opioid scheme ends in prison and hefty fines.

Why the NABP says Canada isn't a safe alternative.

How pharmacists are helping to push vital health efforts.

Brand name drug companies are "gaming" the system, according to the FDA head.

Legislators say it will help ease the problem, but the NCPA says it’s just one part of the solution.

The PBM giant is cutting down on the number of opioids new patients can buy.

The settlement is the end of a long legal battle.

New Walgreens website will showcase the chain’s research on adherence and other topics.

After many years of speculation, a number of biosimilar drugs are hitting the U.S. market.

A tricky labeling system could be affecting your patients.

Generic drugs make up 90% of prescriptions.

Where are today's grads going (and why are there fewer of them)?

Savings from generic and biosimilar drugs are making PBMs and pharmacies, as well as patients, happy.

Biosimilars are starting to come on the market, but some have questions about their safety.

Pharmacists will have a central role in educating about biosimilar drugs.

Biosimilars are now being dispensed from community pharmacies.

The provided droppers may have been mislabeled.

NASP takes aim at DIR fees.

A 5% drop in MMR vaccine use could lead to as much as $4.1 million in health-care costs.

Parents of teenagers are often unaware that their teen children have not had all the vaccinations they need.

Maybe the health-care industry could learn something from Pete Kreckel's mother.

How can we better engage patients for greater adherence rates?

Pharmacists are a source of education for students and parents.